In 2023, the use of antiinfective medicine in the Netherlands stood at X Units (Defined Daily Dosage) Per Thousand Persons Per Day. Forecasted data for 2024 to 2028 show a consistent value of 9.5, indicating no change in the expected utilization over these years. This static value points to a stable year-on-year variation of 0% from 2024 to 2028. Over the last two years, the variation has similarly shown no change, yielding a 0% variation. The Compound Annual Growth Rate (CAGR) over the last five years also reflects a stable pattern with a 0% average annual change.
Future trends to watch for in the antiinfective medicine sector in the Netherlands include:
- Potential advancements in medical research leading to more effective or alternative treatments.
- Changes in disease prevalence, which may alter the demand for antiinfective medications.
- Policy shifts regarding the prescription and usage of such medicines, possibly impacting overall consumption rates.
- Societal factors such as aging populations or changes in public health strategies that could influence usage patterns.
